Thomas P Miller

  • 19175 Citations
  • 57 h-Index
1978 …2021

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2004

The limits of limited stage lymphoma

Miller, T. P., Dec 1 2004, In : Journal of Clinical Oncology. 22, 15, p. 2982-2984 3 p.

Research output: Contribution to journalEditorial

39 Scopus citations

Utility of fine-needle aspiration as a diagnostic technique in lymphoma

Hehn, S. T., Grogan, T. M. & Miller, T. P., Dec 1 2004, In : Journal of Clinical Oncology. 22, 15, p. 3046-3052 7 p.

Research output: Contribution to journalReview article

167 Scopus citations

What is the treatment of choice for advanced-stage Hodgkin's lymphoma: ABVD, Stanford V, or BEACOPP?

Hehn, S. T. & Miller, T. P., Jan 2004, In : Current hematology reports. 3, 1, p. 17-26 10 p.

Research output: Contribution to journalReview article

10 Scopus citations
2003

A phase 2 trial of CHOP chemotherapy followed by tositumomab/iodine I 131 tositumomab for previously untreated follicular non-Hodgkin lymphoma: Southwest Oncology Group Protocol S9911

Press, O. W., Unger, J. M., Braziel, R. M., Maloney, D. G., Miller, T. P., LeBlanc, M., Gaynor, E. R., Rivkin, S. E. & Fisher, R. I., Sep 1 2003, In : Blood. 102, 5, p. 1606-1612 7 p.

Research output: Contribution to journalArticle

151 Scopus citations

Combination of fludarabine and mitoxantrone in untreated stages III and IV low-grade lymphoma: S9501

Velasquez, W. S., Lew, D., Grogan, T. M., Spiridonidis, C. H., Balcerzak, S. P., Dakhil, S. R., Miller, T. P., Lanier, K. S., Chapman, R. A. & Fisher, R. I., May 15 2003, In : Journal of Clinical Oncology. 21, 10, p. 1996-2003 8 p.

Research output: Contribution to journalArticle

50 Scopus citations

Directed indices for exploring gene expression data

LeBlanc, M., Kooperberg, C., Grogan, T. M. & Miller, T. P., Apr 12 2003, In : Bioinformatics. 19, 6, p. 686-693 8 p.

Research output: Contribution to journalArticle

9 Scopus citations

Dose-intense chemotherapy every 2 weeks with dose-intense cyclophosphamide, doxorubicin, vincristine, and prednisone may improve survival in intermediate- and high-grade lymphoma: A phase II study of the Southwest Oncology Group (SWOG 9349)

Blayney, D. W., LeBlanc, M. L., Grogan, T., Gaynor, E. R., Chapman, R. A., Spiridonidis, C. H., Taylor, S. A., Bearman, S. I., Miller, T. P. & Fisher, R. I., Jul 1 2003, In : Journal of Clinical Oncology. 21, 13, p. 2466-2473 8 p.

Research output: Contribution to journalArticle

68 Scopus citations

Gene expression profile of serial samples of transformed B-cell lymphomas

De Vos, S., Hofmann, W. K., Grogan, T. M., Krug, U., Schrage, M., Miller, T. P., Braun, J. G., Wachsman, W., Koeffler, H. P. & Said, J. W., Feb 1 2003, In : Laboratory Investigation. 83, 2, p. 271-285 15 p.

Research output: Contribution to journalArticle

Open Access
93 Scopus citations

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

Rosenwald, A., Wright, G., Leroy, K., Yu, X., Gaulard, P., Gascoyne, R. D., Chan, W. C., Zhao, T., Haioun, C., Greiner, T. C., Weisenburger, D. D., Lynch, J. C., Vose, J., Armitage, J. O., Smeland, E. B., Kvaloy, S., Holte, H., Delabie, J., Campo, E., Montserrat, E. & 18 others, Lopez-Guillermo, A., Ott, G., Muller-Hermelink, H. K., Connors, J. M., Braziel, R., Grogan, T. M., Fisher, R. I., Miller, T. P., LeBlanc, M., Chiorazzi, M., Zhao, H., Yang, L., Powell, J., Wilson, W. H., Jaffe, E. S., Simon, R., Klausner, R. D. & Staudt, L. M., Sep 15 2003, In : Journal of Experimental Medicine. 198, 6, p. 851-862 12 p.

Research output: Contribution to journalArticle

799 Scopus citations

Mood alterations in patients treated with chlorambucil

Hehn, S. T., Dorr, R. T. & Miller, T. P., Dec 2003, In : Clinical Lymphoma. 4, 3, p. 179-182 4 p.

Research output: Contribution to journalArticle

4 Scopus citations

The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

Rosenwald, A., Wright, G., Wiestner, A., Chan, W. C., Connors, J. M., Campo, E., Gascoyne, R. D., Grogan, T. M., Muller-Hermelink, H. K., Smeland, E. B., Chiorazzi, M., Giltnane, J. M., Hurt, E. M., Zhao, H., Averett, L., Henrickson, S., Yang, L., Powell, J., Wilson, W. H., Jaffe, E. S. & 19 others, Simon, R., Klausner, R. D., Montserrat, E., Bosch, F., Greiner, T. C., Weisenburger, D. D., Sanger, W. G., Dave, B. J., Lynch, J. C., Vose, J., Armitage, J. O., Fisher, R. I., Miller, T. P., LeBlanc, M., Ott, G., Kvaloy, S., Holte, H., Delabie, J. & Staudt, L. M., Feb 2003, In : Cancer Cell. 3, 2, p. 185-197 13 p.

Research output: Contribution to journalArticle

690 Scopus citations
2002

External beam radiation therapy in the treatment of patients with extranodal stage IA non-Hodgkin's lymphoma

Briggs, J. H., Algan, Ö., Miller, T. P. & Oleson, J. R., Feb 18 2002, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 25, 1, p. 34-37 4 p.

Research output: Contribution to journalArticle

7 Scopus citations

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

Rosenwald, A., Wright, G., Chan, W. C., Connors, J. M., Campo, E., Fisher, R. I., Gascoyne, R. D., Konrad Muller-Hermelink, H., Smeland, E. B., Giltnane, J. M., Hurt, E. M., Zhao, H., Averett, L., Yang, L., Wilson, W. H., Jaffe, E. S., Simon, R., Klausner, R. D., Powell, J., Duffey, P. L. & 20 others, Longo, D. L., Greiner, T. C., Weisenburger, D. D., Sanger, W. G., Dave, B. J., Lynch, J. C., Vose, J., Armitage, J. O., Montserrat, E., López-Guillermo, A., Grogan, T. M., Miller, T. P., Leblanc, M., Ott, G., Kvaloy, S., Delabie, J., Holte, H., Krajci, P., Stokke, T. & Staudt, L. M., Jun 20 2002, In : New England Journal of Medicine. 346, 25, p. 1937-1947 11 p.

Research output: Contribution to journalArticle

2762 Scopus citations
2001

Infusional CHOP chemotherapy (CVAD) with or without chemosensitizers offers no advantage over standard CHOP therapy in the treatment of lymphoma: A Southwest Oncology Group Study

Gaynor, E. R., Unger, J. M., Miller, T. P., Grogan, T. M., White, J., Mills, G. M., Balcerzak, S. P., Varterasian, M., LeBlanc, M. & Fisher, R. I., Feb 1 2001, In : Journal of Clinical Oncology. 19, 3, p. 750-755 6 p.

Research output: Contribution to journalArticle

27 Scopus citations

Phase III randomized intergroup trial of subtotal lymphoid irradiation versus doxorubicin, vinblastine, and subtotal lymphoid irradiation for stage IA to IIA Hodgkin's disease

Press, O. W., LeBlanc, M., Lichter, A. S., Grogan, T. M., Unger, J. M., Wasserman, T. H., Gaynor, E. R., Peterson, B. A., Miller, T. P. & Fisher, R. I., Nov 15 2001, In : Journal of Clinical Oncology. 19, 22, p. 4238-4244 7 p.

Research output: Contribution to journalArticle

118 Scopus citations

The Burkitt-like lymphomas: A Southwest Oncology Group study delineating phenotypic, genotypic, and clinical features

Braziel, R. M., Arber, D. A., Slovak, M. L., Gulley, M. L., Spier, C., Kjeldsberg, C., Unger, J., Miller, T. P., Tubbs, R., Leith, C., Fisher, R. I. & Grogan, T. M., Jun 15 2001, In : Blood. 97, 12, p. 3713-3720 8 p.

Research output: Contribution to journalArticle

89 Scopus citations
2000

Combined chemotherapy plus radiotherapy for treatment of early-stage intermediate- and high-grade non-Hodgkin's lymphoma.

Briggs, J. H. & Miller, T. P., Mar 2000, In : Current oncology reports. 2, 2, p. 176-181 6 p.

Research output: Contribution to journalReview article

6 Scopus citations

Interferon alfa consolidation after intensive chemotherapy does not prolong the progression-free survival of patients with low-grade non- Hodgkin's lymphoma: Results of the Southwest Oncology Group randomized phase III study 8809

Fisher, R. I., Dana, B. W., LeBlanc, M., Kjeldsberg, C., Forman, J. D., Unger, J. M., Balcerzak, S. P., Gaynor, E. R., Roy, V. & Miller, T., May 2000, In : Journal of Clinical Oncology. 18, 10, p. 2010-2016 7 p.

Research output: Contribution to journalArticle

75 Scopus citations

Interferon does not prolong progression-free survival after ProMACE-MOPP [5] (multiple letters)

Cabanillas, F., Fisher, R. I., Leblanc, M. & Miller, T., Sep 15 2000, In : Journal of Clinical Oncology. 18, 18, 1 p.

Research output: Contribution to journalLetter

Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma

Stopeck, A. T., Gessner, A., Miller, T. P., Hersh, E. M., Johnson, C. S., Cui, H., Frutiger, Y. & Grogan, T. M., Jan 1 2000, In : Clinical Cancer Research. 6, 10, p. 3904-3909 6 p.

Research output: Contribution to journalArticle

56 Scopus citations

Phase II evaluation of interleukin-4 in patients with non-Hodgkin's lymphoma: A Southwest oncology group trial

Taylor, C. W., LeBlanc, M., Fisher, R. I., Moore, D. F., Roach, R. W., Elias, L. & Miller, T. P., Dec 19 2000, In : Anti-cancer drugs. 11, 9, p. 695-700 6 p.

Research output: Contribution to journalArticle

18 Scopus citations
1999

Phase II trial of menogaril in non-Hodgkin's lymphomas: A southwest oncology group trial

Moore, D. F., Brown, T. D., LeBlanc, M., Dahlberg, S., Miller, T. P., McClure, S. & Fisher, R. I., Dec 22 1999, In : Investigational New Drugs. 17, 2, p. 169-172 4 p.

Research output: Contribution to journalArticle

2 Scopus citations
1998

A phase I/II trial of paclitaxel for non-Hodgkin's lymphoma followed by paclitaxel plus quinine in drug-resistant disease

Miller, T. P., Chase, E. M., Dorr, R., Dalton, W. S., Lam, K. S. & Salmon, S. E., Jan 1 1998, In : Anti-cancer drugs. 9, 2, p. 135-140 6 p.

Research output: Contribution to journalArticle

25 Scopus citations

Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma

Miller, T. P., Dahlberg, S., Cassady, J. R., Adelstein, D. J., Spier, C. M., Grogan, T. M., LeBlanc, M., Carlin, S., Chase, E. & Fisher, R. I., Jul 2 1998, In : New England Journal of Medicine. 339, 1, p. 21-26 6 p.

Research output: Contribution to journalArticle

801 Scopus citations

Management of intermediate-grade lymphomas

Miller, T. P., Dec 5 1998, In : ONCOLOGY. 12, 10 SUPPL. 8, p. 35-39 5 p.

Research output: Contribution to journalReview article

6 Scopus citations

New REAL clinical entities

Fisher, R. I., Miller, T. P. & Grogan, T. M., Jul 29 1998, In : Cancer Journal from Scientific American. 4, SUPPL. 2, p. S5-S12

Research output: Contribution to journalArticle

12 Scopus citations

Treatment of intermediate-grade and high-grade non-Hodgkin's lymphoma [1] (multiple letters)

Wirth, A., Prince, H. M., Wolf, M., Machida, U., Kami, M., Hirai, H., Mounier, N., Gisselbrecht, C., Lepage, E., Kosmas, C., Malamos, N. A., Antonopoulos, M. J., Decaudin, D., Miller, T., LeBlanc, M. & Fisher, R. I., Nov 12 1998, In : New England Journal of Medicine. 339, 20, p. 1475-1477 3 p.

Research output: Contribution to journalLetter

1 Scopus citations
1997

A southwest oncology group perspective on the revised European-American lymphoma classification

Grogan, T. M., Miller, T. P., Fisher, R. I. & Graff, J. C., Jan 1 1997, In : Hematology/Oncology Clinics of North America. 11, 5, p. 819-846 28 p.

Research output: Contribution to journalArticle

11 Scopus citations

Follicular lymphomas: Do histologic subtypes predict outcome?

Miller, T. P., LeBlanc, M., Grogan, T. M., Fisher, R. I. & Graff, J. C., Jan 1 1997, In : Hematology/Oncology Clinics of North America. 11, 5, p. 893-900 8 p.

Research output: Contribution to journalArticle

43 Scopus citations
1996

The phenomenon of multidrug resistance in non-Hodgkin's lymphoma.

Miller, T. P., Chase, E. M., Dalton, W. S. & Grogan, T. M., 1996, In : Cancer treatment and research. 85, p. 107-117 11 p.

Research output: Contribution to journalReview article

6 Scopus citations
1995

A clinical analysis of two indolent lymphoma entities: Mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): A Southwest Oncology Group study

Fisher, R. I., Dahlberg, S., Nathwani, B. N., Banks, P. M., Miller, T. P. & Grogan, T. M., Jan 1 1995, In : Blood. 85, 4, p. 1075-1082 8 p.

Research output: Contribution to journalArticle

Open Access
307 Scopus citations
1994

A phase III comparison of CHOP vs. m-BACOD vs. ProMACE-CytaBOM vs. MACOP-B in patients with intermediate- or high-grade non-Hodgkin's lymphoma: Results of SWOG-8516 (Intergroup 0067), the National High-Priority Lymphoma Study

Fisher, R. I., Gaynor, E. R., Dahlberg, S., Oken, M. M., Grogan, T. M., Mize, E. M., Glick, J. H., Coltman, C. A. & Miller, T. P., Feb 23 1994, In : Annals of Oncology. 5, SUPPL. 2, p. 91-95 5 p.

Research output: Contribution to journalArticle

64 Scopus citations

A Southwest Oncology Group phase II evaluation of fluderabine monophosphate in sarcoma

Grever, M. R., Benedetti, J., Balcerzak, S. P., Taylor, S. A., Miller, T. P. & Dakhil, S. R., Sep 1 1994, In : Investigational New Drugs. 12, 3, p. 259-261 3 p.

Research output: Contribution to journalArticle

1 Scopus citations

Low-dose involved field radiation after chemotherapy in advanced Hodgkin disease: A Southwest Oncology Group randomized study

Fabian, C. J., Mansfield, C. M., Dahlberg, S., Jones, S. E., Miller, T. P., Van Slyck, E., Grozea, P. N., Morrison, F. S., Coltman, C. A. & Fisher, R. I., Jun 1 1994, In : Annals of internal medicine. 120, 11, p. 903-912 10 p.

Research output: Contribution to journalArticle

149 Scopus citations

Phase II evaluation of mitoxantrone plus cis-platinum in patients with advanced breast cancer - A Southwest Oncology Group study

Atiba, J. O., Green, S. J., Hynes, H. E., Osborne, C. K., Miller, T. P. & Davidner, M., Jun 1 1994, In : Investigational New Drugs. 12, 2, p. 129-132 4 p.

Research output: Contribution to journalArticle

5 Scopus citations

Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: A prospective Southwest Oncology Group trial

Miller, T. P., Grogan, T. M., Dahlberg, S., Spier, C. M., Braziel, R. M., Banks, P. M., Foucar, K., Kjeldsberg, C. R., Levy, N., Nathwani, B. N., Schnitzer, B., Tubbs, R. R., Gaynor, E. R. & Fisher, R. I., Mar 15 1994, In : Blood. 83, 6, p. 1460-1466 7 p.

Research output: Contribution to journalArticle

219 Scopus citations

The presence of bcl-l and bci-2 gene rearrangements in diffuse small cleaved-cell lymphoma

Leith, C. P., Willman, C. L., Spier, C. M., Miller, T. P. & Grogan, T. M., Sep 1994, In : Diagnostic Molecular Pathology. 3, 3, p. 178-183 6 p.

Research output: Contribution to journalArticle

2 Scopus citations
1993

Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's Lymphoma

Fisher, R. I., Gaynor, E. R., Dahlberg, S., Oken, M. M., Grogan, T. M., Mize, E. M., Glick, J. H., Coltman, C. A. & Miller, T. P., Apr 8 1993, In : New England Journal of Medicine. 328, 14, p. 1002-1006 5 p.

Research output: Contribution to journalArticle

1888 Scopus citations

Deficient tumor-infiltrating T-lymphocyte response in malignant lymphoma: Relationship to HLA expression and host immunocompetence

List, A. F., Spier, C. M., Miller, T. P. & Grogan, T. M., Mar 1993, In : Leukemia. 7, 3, p. 398-403 6 p.

Research output: Contribution to journalArticle

45 Scopus citations

Immunobiologic correlates of prognosis in lymphoma

Grogan, T. M. & Miller, T. P., Jan 1 1993, In : Seminars in Oncology. 20, SUPPL. 5, p. 58-74 17 p.

Research output: Contribution to journalReview article

11 Scopus citations

Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy

Dana, B. W., Dahlberg, S., Nathwani, B. N., Chase, E., Coltman, C., Miller, T. P. & Fisher, R. I., Jan 1 1993, In : Journal of Clinical Oncology. 11, 4, p. 644-651 8 p.

Research output: Contribution to journalArticle

185 Scopus citations

NCAM (CD56)-positive malignant lymphoma

Kern, W. F., Spier, C. M., Miller, T. P. & Grogan, T. M., Jan 1 1993, In : Leukemia and Lymphoma. 12, 1-2, p. 1-10 10 p.

Research output: Contribution to journalArticle

40 Scopus citations

Radiation therapy salvage of Hodgkin's disease following chemotherapy failure

Leigh, B. R., Fox, K. A., Mack, C. F., Baier, M., Miller, T. P. & Cassady, J. R., Nov 15 1993, In : International Journal of Radiation Oncology, Biology, Physics. 27, 4, p. 855-862 8 p.

Research output: Contribution to journalArticle

35 Scopus citations

Treatment of diffuse large-cell lymphoma: a summary of outcome for patients treated by Southwest Oncology Group.

Miller, T. P. & Dahlberg, S., 1993, In : Cancer treatment and research. 66, p. 53-63 11 p.

Research output: Contribution to journalReview article

4 Scopus citations
1992

Diffuse small cleaved-cell lymphoma: A heterogeneous disease with distinct immunobiologic subsets

Leith, C. P., Spier, C. M., Grogan, T. M., Gonzales, G., Rangel, C. S., Rybski, J. A., Matzner, M. & Miller, T. P., Jan 1 1992, In : Journal of Clinical Oncology. 10, 8, p. 1259-1265 7 p.

Research output: Contribution to journalArticle

15 Scopus citations

Neural cell adhesion molecule-positive peripheral T-cell lymphoma: A rare variant with a propensity for unusual sites of involvement

Kern, W. F., Spier, C. M., Hanneman, E. H., Miller, T. P., Matzner, M. & Grogan, T. M., Jan 1 1992, In : Blood. 79, 9, p. 2432-2437 6 p.

Research output: Contribution to journalArticle

215 Scopus citations
1991

A clinical phase II study of ProMACE-CytaBOM [1]

Dahlberg, S., Miller, T. P. & Fisher, R. I., Jan 1 1991, In : Journal of Clinical Oncology. 9, 5, 1 p.

Research output: Contribution to journalLetter

Activity of esorubicin in recurrent malignant lymphoma: A southwest oncology group study

Miller, T. P., Dahlberg, S., Salmon, S. E., Williamson, S. K., Belt, R. J., Dana, B. W. & Fisher, R. I., Jan 1 1991, In : Journal of Clinical Oncology. 9, 7, p. 1204-1209 6 p.

Research output: Contribution to journalArticle

Combination chemotherapy of intermediate-grade and high-grade non-Hodgkin's lymphoma with MACOP-B: A Southwest Oncology Group study

Weick, J. K., Dahlberg, S., Fisher, R. I., Dana, B., Miller, T. P., Balcerzak, S. P. & Pierce, H. I., Jan 1 1991, In : Journal of Clinical Oncology. 9, 5, p. 748-753 6 p.

Research output: Contribution to journalArticle

36 Scopus citations

Long-term follow-up of ProMACE-CytaBOM in non-Hodgkin's lymphomas

Fisher, R. I., Longo, D. L., DeVita, V. T., Hubbard, S. M., Miller, T. P. & Young, R. C., Jan 1 1991, In : Annals of Oncology. 2, SUPPL. 1, p. 33-35 3 p.

Research output: Contribution to journalArticle

Open Access
27 Scopus citations